Sign in
CompletedNo phase

TipTraQ Home Sleep Test Study, SHH

Key facts

Who runs it
PranaQ Pte. Ltd.
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
112 people enrolled
Started
1 Mar 2023
Ended
27 Mar 2024
Type of study
Observational
Record updated
18 October 2024

Who can take part

Age
20 years to 80 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Subjects from the age of 20 and older that have an indication for an in-lab PSG study

Who cannot take part

  • Chronic opioid medication user
  • Heart transplant
  • Heart failure, New Youk Heart Association (NYHA) classification III or IV
  • Devastating severe strokes, with the modified Rankin score (mRS)≥4
  • Tracheostomy
  • Incapable of comprehending and signing the informed consent and questionnaires, including but not limited to subjects with severe Alzheimer's, unconscious by head trauma, or of someone with limited mental capacity
  • Cannot correctly follow the order to use the TipTraQ device

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The clinical study aims to develop and validate the TipTraQ system, created by PranaQ, a home sleep test for sleep apnea screening. The system comprises a wearable device and a cloud-based AI for estimating Total Sleep Time (TST) and Apnea-Hypopnea Index (AHI).

The group in the trial

  • Healthy or people who has indication to conduct polysomnography (PSG).

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Feasibility Evaluation of Sleep Apnea Screening with Photoplethysmography
Publications
Record updated
18 October 2024